Trial Design Articles

Complex, Puzzling, Ill-Defined: Challenges in Assessing PTSD

Oct 10, 2018

By Krista Armstrong

A recurring challenge in assessing and treating Post-Traumatic Stress Disorder or PTSD is the inherently complex, ill-defined, and sometimes downright puzzling nature of its symptoms.

Alzheimer’s Clinical Trials: Obstacles and Opportunities

Oct 09, 2018

By Krista Armstrong, Sebastian Turek

For sponsors who are pursuing the goal of treating Alzheimer’s disease, understanding the obstacles inherent in Alzheimer’s clinical trials can help in planning for, and overcoming, these challenges.

Mid-Sized CROs Consolidate in Specialized Therapeutic Areas

Sep 10, 2018

By Moe Alsumidaie

Columnist Moe Alsumidae speaks to key Synteract executives on their acquisition of a dermatology CRO to augment its own expertise and grow the specific services necessary for this therapeutic specialty.

Cancer Immunotherapy Biomarkers: Four Trends to Watch

May 29, 2018

By Nina Baluja, M.D.

Here are four trends to watch as researchers continue to make headway in the development of biomarkers for cancer immunotherapy.

How to Minimize Subjectivity in Dermatology Data

Dec 18, 2017

By Darcee Duke Strube

Until more sophisticated measures are created, a combination of investigator training and new imaging methods is the best way to create accurate, reproducible data across sites.

native1_300x100
lorem ipsum